Description | The antibody COVOX-278 is a human mAb specific for SARS-CoV-2 Spike S1 protein. Neutralization and binding of mAb are affected for B.1.617.1 and B.1.617.2, and we inferred that the mutation of RBD residue 452 was responsible. |
Clonality | Monoclonal |
Host Species | Human |
Target Species | SARS-CoV-2 (B.1.617.1 and B.1.617.2 variant) |
Epitope | RBD receptor binding domain and residue 452 is a key site. |
Isotype | IgG1 |
Expression Species | HEK293F or CHO cell line |
Conjugation | Unconjugated |
Purity | >95% |
Endotoxin | <1 EU/mg |
Form | Liquid |
Purification | Protein A purified |
Sterility | 0.2 μM filtered |
Formulation | PBS, pH 7.4 |
Preservation | No preservatives |
Stabilizer | No stabilizers |
Storage | Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics. |
Application | ELISA, Neut |
ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
WB | Western Blot Protocol |
FC | Western Blot Protocol |
Target | SARS-CoV-2 |
Alternative Name | Severe acute respiratory syndrome coronavirus 2 |
Research Area | Coronavirus Disease 2019 |
Related Disease | Coronavirus Disease 2019 |